FDA Approves Viatris, Ocuphire’s Eye Drops to Reverse Pupil Dilation

[cafead]

via The FDA on Wednesday approved Ocuphire and Viatris’ phentolamine ophthalmic solution, now to be marketed as Ryzumvi, for the reversal of pharmacologically-induced mydriasis.

article source